S&P 500

5.942,47

1,26%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
AC Immune SA (ACIU)
AC Immune SA (ACIU) Notícias

ACIU

AC Immune (ACIU)

AC Immune SA

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ACIU

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
18/12/2024	19:16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
13/12/2024	19:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ACIU	AC Immune SA
10/12/2024	09:00	GlobeNewswire Inc.	AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome	NASDAQ:ACIU	AC Immune SA
14/11/2024	09:00	GlobeNewswire Inc.	AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease	NASDAQ:ACIU	AC Immune SA
13/11/2024	09:00	GlobeNewswire Inc.	AC Immune to Present at the Jefferies 2024 London Healthcare Conference	NASDAQ:ACIU	AC Immune SA
05/11/2024	09:00	GlobeNewswire Inc.	AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update	NASDAQ:ACIU	AC Immune SA
27/09/2024	17:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACIU	AC Immune SA
06/08/2024	17:50	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ACIU	AC Immune SA
01/08/2024	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACIU	AC Immune SA
26/07/2024	17:53	Edgar (US Regulatory)	Form F-3/A - Registration statement by foreign private issuers: [Amend]	NASDAQ:ACIU	AC Immune SA
09/02/2024	18:30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ACIU	AC Immune SA
03/01/2024	10:10	GlobeNewswire Inc.	AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases	NASDAQ:ACIU	AC Immune SA
27/06/2023	14:30	AllPennyStocks.com	Biotech Pops On FDA Fast Track Designation	NASDAQ:ACIU	AC Immune SA
27/06/2023	09:23	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ACIU	AC Immune SA
27/06/2023	09:11	Dow Jones News	AC Immunity Shares Jump 18% After Fast-Track Designation on Alzheimer's Treatment	NASDAQ:ACIU	AC Immune SA
16/03/2023	08:32	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:ACIU	AC Immune SA
10/02/2023	18:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACIU	AC Immune SA
01/12/2022	10:45	TipRanks	H.C. Wainwright Keeps Their Buy Rating on AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
02/11/2022	01:45	TipRanks	SVB Securities Sticks to Its Buy Rating for AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
31/10/2022	07:15	TipRanks	AC Immune SA (ACIU) Receives a Buy from H.C. Wainwright	NASDAQ:ACIU	AC Immune SA
29/08/2022	00:15	TipRanks	SVB Securities Keeps Their Buy Rating on AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
11/07/2022	09:40	TipRanks	SVB Securities Thinks AC Immune SA’s Stock is Going to Recover	NASDAQ:ACIU	AC Immune SA
19/06/2022	04:05	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
16/06/2022	07:57	Dow Jones News	AC Immune Shares Fall Premarket on Alzheimer's Study Miss	NASDAQ:ACIU	AC Immune SA
29/04/2022	07:26	TipRanks	H.C. Wainwright Thinks AC Immune SA’s Stock is Going to Recover	NASDAQ:ACIU	AC Immune SA
21/12/2021	04:11	TipRanks	Leerink Partners Sticks to Its Buy Rating for AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
12/11/2021	11:44	Dow Jones News	AC Immune Sees Positive Data in Trial for Alzheimer's Disease Treatment	NASDAQ:ACIU	AC Immune SA
31/08/2021	11:55	Dow Jones News	AC Immune Shares Rally on Renewed Hope for Semorinemab in Alzheimer's	NASDAQ:ACIU	AC Immune SA
31/08/2021	09:33	Dow Jones News	AC Immune: Semorinemab Meets Co-Primary Endpoint in Alzheimer's Disease	NASDAQ:ACIU	AC Immune SA
05/08/2021	18:16	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ACIU	AC Immune SA